The anterior saphenous vein. Part 4. Clinical and technical considerations in treatment. Endorsed by the American Vein and Lymphatic Society, the American Venous Forum, and the International Union of Phlebology.

Autor:	Boyle EM; Inovia Vein Specialty Centers, Bend, OR, USA., Drgastin R; Inovia Vein Specialty Centers, Bend, OR, USA., Labropoulos N; Division of Vascular Surgery, Department of Surgery, Stony Brook Medicine, Stony Brook, NY, USA., Caggiati A; Department of Anatomy, University 'La Sapienza', Rome, Italy., Gasparis A; Division of Vascular Surgery, Department of Surgery, Stony Brook Medicine, Stony Brook, NY, USA., Doganci S; Department of Cardiovascular Surgery, Health Sciences University, Gulhane School of Medicine, Ankara, Turkey., Meissner M; Division of Vascular Surgery, Department of Surgery, University of Washington Medical Center, Seattle, WA, USA.
Jazyk:	angličtina
Zdroj:	Phlebology [Phlebology] 2024 Jun; Vol. 39 (5), pp. 333-341. Date of Electronic Publication: 2023 Dec 21.
DOI:	10.1177/02683555231223063
Abstrakt:	Background: The decision to treat a refluxing anterior saphenous vein (ASV) should be a clinical decision based on the assessment on the ASV's contribution to patient's signs and symptoms. Once the decision to treat has been made, there are anatomic, clinical, and technical considerations in treatment planning. Methods: Clinical scenarios were discussed by a panel of experts and common anatomic, clinical, and technical considerations were identified. Results: There are unique clinical considerations such as whether both the great saphenous vein (GSV) and ASV should be concomitantly treated, if a normal ASV should be treated when treating a refluxing GSV and when and how to treat the associated tributary varicose tributaries. Being aware of the anatomic, clinical, and technical considerations allows development of a treatment plan that optimizes long-term outcomes in patients with ASV reflux. Conclusion: Ultimately the treatment plan should be tailored to address these types of variables in a patient-centered discussion. Competing Interests: Declaration of conflicting interestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: RD, EB, AC, SD, and MM reports no conflicts. NL is a Consultant/Speaker with Philips, Medtronic, BD Bard, and Boston Scientific; AG is a Consultant/Speaker: Medtronic, BD Bard, and Boston Scientific.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu